PharmiWeb49 分钟
Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of ...
VANCOUVER, BC / ACCESS Newswire / February 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H ,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its ...